Cargando…
Relationship of Myocardial Gadolinium Enhancement to Late Clinical Outcomes: Implications for the COVID-19 era
Autores principales: | Morris, Paraskevi, Lal, Sean, Bao, Shisan, Dennis, Mark, Hunyor, Imre, O’Sullivan, John, Grieve, Stuart M., Puranik, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558819/ https://www.ncbi.nlm.nih.gov/pubmed/34736825 http://dx.doi.org/10.1016/j.hlc.2021.08.010 |
Ejemplares similares
-
LAMP2 shines a light on cardiomyopathy in an athlete
por: Martin, Sophie, et al.
Publicado: (2017) -
Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI
por: Doltra, Adelina, et al.
Publicado: (2013) -
Role of Late Gadolinium Enhancement in the Assessment of Myocardial Viability
por: Shah, Dr. Viraj, et al.
Publicado: (2022) -
Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19
por: Law, Ching Chee, et al.
Publicado: (2021) -
Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis()
por: Rajesh, Gopalan Nair, et al.
Publicado: (2017)